ALAM
UTHR icon

Asahi Life Asset Management’s United Therapeutics UTHR Stock Holding History

Asahi Life Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,450
Closed -$333K – 220
2024
Q1 		$333K Buy
+1,450
New +$327K 0.2% 134
2023
Q3 		– Sell
-1,290
Closed -$285K – 240
2023
Q2 		$285K Buy
+1,290
New +$286K 0.09% 156

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Asahi Life Asset Management's UTHR Position: Q2 2024 in Review

Asahi Life Asset Management sold out of United Therapeutics (UTHR) in Q2 2024, closing a stake of 1,450 shares — an estimated $333K sold.

Asahi Life Asset Management first reported a position in UTHR in Q2 2023 and held it in 2 quarters. The position peaked at $333K in Q1 2024. 568 funds tracked by Wall St. Rank hold UTHR as of Q2 2024.

  • Asahi Life Asset Management reported no remaining United Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Asahi Life Asset Management sold 1,450 United Therapeutics shares in Q2 2024, an estimated $333K.
  • Asahi Life Asset Management first reported a position in United Therapeutics in Q2 2023 and held it in 2 quarters.
  • Asahi Life Asset Management's United Therapeutics position peaked at $333K in Q1 2024.
  • 568 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2024.

Based on Asahi Life Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.